Mar 02, 2021
Press Releases
ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes
Agreement extends research and clinical development across ViaCyte’s full product portfolio and Gore’s full materials and device proprietary technologies Preclinical and clinical studies show that novel membranes and devices designed and developed by the collaboration both improve engraftment and reduce body’s immune reaction ViaCyte’s Phase 2 clinical study of closed device featuring Gore’s novel membrane […]